Medical Condition News

RSS

New guidelines outline criteria for stroke centers offering ischemic stroke interventions to patients

The Society of NeuroInterventional Surgery today joined 12 other neurointerventional societies to release new guidelines outlining the criteria for Level 1, 2 and 3 stroke centers that provide acute ischemic stroke interventions to stroke patients.

7 Sep 2018

Mayo Clinic physicians win SU2C Catalyst Award to fund melanoma research

Mayo Clinic physicians Matthew Block, M.D., Ph.D. and Tina Hieken, M.D., have received a Stand up to Cancer Catalyst Award to fund melanoma research and a neoadjuvant clinical trial.

7 Sep 2018

Ground-breaking therapeutic process can destroy bowel cancer cells

Researchers at Queen's University Belfast have discovered a ground-breaking therapeutic process that can target and kill bowel cancer cells, which may improve survival rates for bowel cancer patients globally.

6 Sep 2018

Sexuality essentially silenced following stroke

Stroke survivors and their partners are not adequately supported to deal with changes to their relationships, self-identity, gender roles and intimacy following stroke, according to new research from the University of Sydney.

6 Sep 2018

Researchers discover link between invisible dark matter particles and melanoma

In a paper to be published in the September 2018 issue of Biophysical Reviews and Letters, researchers have discovered that there is a correlation and possible cause and effect between otherwise invisible dark matter particles and melanoma, a type of skin cancer.

6 Sep 2018

New diagnostic tool for difficult-to-detect cancers

A new diagnostic tool is expected to result in better treatment of cancer that is difficult to diagnose. The tool was developed by cancer researchers at Sahlgrenska Academy and doctors at the Sahlgrenska University Hospital, Sweden. Their study, which has been published in JCO Precision Oncology, started with a single cancer patient.

6 Sep 2018

Natural plant compound exploits newly identified Achilles' heel in uveal melanoma

A natural plant compound exploits a newly identified Achilles' heel in a cancer of the eye, uveal melanoma. In human cancer cells growing in the lab, the compound shuts down the overactive signaling that drives uveal melanoma cell growth, according to researchers at Washington University School of Medicine in St. Louis.

6 Sep 2018

Free online Heart Age Test reveals likelihood of having a heart attack

PHE is running a campaign to encourage people to take a free online Heart Age Test to see whether they are at an increased risk of having a heart attack.

6 Sep 2018

Autism biomarker may aid early diagnoses

A newly discovered group of blood metabolites could act as a biomarker to accelerate the diagnosis of autism spectrum disorder.

6 Sep 2018

Brief sleep intervention reduces risk of obesity years later

When it comes to obesity prevention, sleep is not usually something that springs to mind, but a University of Otago research team has found we should not underestimate its importance.

6 Sep 2018

Newly discovered marker can identify patients who would benefit from novel asthma treatments

Researchers at RCSI, Stanford University and Oregon Health Sciences University have discovered a marker which can help determine which asthma patients are likely to benefit from a new treatment which targets inflammatory cells called Eosinophils.

6 Sep 2018

Mycovia initiates two Phase 3 clinical trials to evaluate VT-1161 in patients with RVVC

Mycovia Pharmaceuticals, making its official debut as a company developing therapies in women's health and dermatology, today announced the initiation of two Phase 3 clinical trials called VIOLET to evaluate the safety and efficacy of its lead candidate, VT-1161, in patients with recurrent vulvovaginal candidiasis

6 Sep 2018

Verastem doses first patient in Phase I/II clinical trial of duvelisib in combination with venetoclax

Verastem, Inc., operating as Verastem Oncology, a biopharmaceutical company focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients, today announced dosing of the first patient in a multicenter Phase I/II clinical trial at the Dana-Farber/Harvard Cancer Center of duvelisib in combination with venetoclax in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma.

6 Sep 2018

BeiGene collaborates with SpringWorks to evaluate new combinational therapy for solid tumors

BeiGene, Ltd., a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, and SpringWorks Therapeutics, a clinical-stage rare disease and oncology company focused on sourcing and developing innovative treatments for underserved patient populations, announced today that the companies have entered into a global clinical collaboration agreement to evaluate the safety, tolerability and preliminary efficacy of combining BeiGene's investigational RAF dimer inhibitor, lifirafenib and SpringWorks Therapeutics' investigational MEK inhibitor, PD-0325901, in patients with advanced solid tumors.

6 Sep 2018

Medical Condition News

New guidelines outline criteria for stroke centers offering ischemic stroke interventions to patients

Mayo Clinic physicians win SU2C Catalyst Award to fund melanoma research

Ground-breaking therapeutic process can destroy bowel cancer cells

Sexuality essentially silenced following stroke

Researchers discover link between invisible dark matter particles and melanoma

New diagnostic tool for difficult-to-detect cancers

Natural plant compound exploits newly identified Achilles' heel in uveal melanoma

Free online Heart Age Test reveals likelihood of having a heart attack

Autism biomarker may aid early diagnoses

Brief sleep intervention reduces risk of obesity years later

Newly discovered marker can identify patients who would benefit from novel asthma treatments

Mycovia initiates two Phase 3 clinical trials to evaluate VT-1161 in patients with RVVC

Verastem doses first patient in Phase I/II clinical trial of duvelisib in combination with venetoclax

BeiGene collaborates with SpringWorks to evaluate new combinational therapy for solid tumors

Study examines link between brain function and impact of life events on depression

Doctor with Guillain Barré syndrome recovers back to normal life

Research finds why foods high in unsaturated fats protect against cardiovascular disease

Researchers develop fully-automated medical image analysis program to detect breast tumors

Researchers discover natural plant compound that shuts down uveal melanoma cell growth

New system accelerates discovery of chemical compounds that inhibit enzyme implicated in cancers

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News